18 and older, any sex, with Physical Activity. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Change in Objective Physical Activity Measured by Accelerometer Measured at Baseline and 18-month Follow-upPrimary· Baseline and 18-month follow-up
* Participants will wear an accelerometer to measure physical activity.
* The outcome measure will measure the weekly minutes of moderate to vigorous physical activity.
* Physical activity was measured using the Freedson Adult cutpoint categories from 1998. Each count was measured every 60 seconds/per minute.
* Sedentary: 0-99 counts per minute
* Light: 100-1951 counts per minute
* Moderate: 1952-5724 counts per minute
* Vigorous: 5725-9498 counts per minute
* Very vigorous: 9499 and up counts per minute
Baseline
Group
Value
95% CI
Multilevel Intervention
63.46
± 84.58
Control
96.94
± 85.32
18-month follow-up
Group
Value
95% CI
Multilevel Intervention
74.02
± 97.63
Control
76.13
± 72.79
Number of Participants Who Met the Subjective Physical Activity Recommendations as Measured by the Global Physical Activity Questionnaire at Baseline and 18-month Follow-upSecondary· Baseline and 18-month follow-up.
* Will use the Global Physical Activity Questionnaire to determine the number of participants who met the physical activity recommendations at baseline and at the 18-month follow-up.
* The Global Physical Activity Questionnaire measures time spent in vigorous and moderate intensity physical activity in the domains of work, travel, and recreation. Participants will answer yes or no to their involvement in a given intensity (e.g., vigorous or moderate) in a given domain. If the participant answers 'yes' they will be asked on how many days do they partake in the activity, and for how many hours a
Baseline
Group
Value
95% CI
Multilevel Intervention
292
Control
287
18-month follow-up
Group
Value
95% CI
Multilevel Intervention
118
Control
102
Sponsor's own description
The purpose of the study is to test a multilevel intervention's impact on increasing physical activity among rural residents. It is expected that participants who participate in more of the intervention (e.g., all levels) will increase their physical activity more than the control group and individuals who participate in less of the intervention (e.g., one level of the intervention).
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
NCT07038317 — A Text Messaging Trial to Test Vaping Health Messages Optimized to Young Adults' Vaping Status
· NA
· not yet recruiting
NCT06112431 — Eye Health Intervention Study in Upper Manhattan
· NA
· not yet recruiting
NCT07202390 — Intraarticular Gold Microparticles for Knee Osteoarthritis
· NA
· not yet recruiting
NCT07444736 — Effect of 8 Weeks of Resistance Training With Blood Flow Restriction on Muscle Strength, Clinical Parameters, Biochemica
· NA
· enrolling by invitation
NCT07376668 — Effects of a WhatsApp-assisted Prehabilitation for Patient Undergoing Elective Colorectal Cancer Surgery
· NA
· not yet recruiting
Other recruiting trials for Physical Activity
Currently open trials in the same condition.
NCT07466797 — The eHealth Integrated Maternal Physical Activity Programme in Prenatal Care Trial (E-IMPACT)
· NA
· recruiting
NCT07466914 — Constipation in Children With Cerebral Palsy
· active not recruiting
NCT07290309 — Survivors Uniting for Remote Guided Exercise
· NA
· recruiting
NCT07415460 — Evaluating the Impact of SKY Breath Meditation on Stress, Well-being, and Connection in College Students
· NA
· recruiting
NCT07585409 — Physical Activity in Persons With Parkinson's Disease
· recruiting
Other Washington University School of Medicine trials
Trials by the same sponsor.
NCT05521997 — Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer
· Phase 2
· not yet recruiting
NCT07101666 — Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer
· Phase 2
· not yet recruiting
NCT07200089 — Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel)
· Phase 1
· not yet recruiting
NCT07313592 — Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients
· not yet recruiting
NCT07419464 — 5-Fluorouracil Response and Optimization STudy (The FROST Trial)
· Phase 2
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Washington University School of Medicine
Last refreshed: 8 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03683173.